TickerFactsScreenerDevelopers

Telomir Pharmaceuticals, Inc. (TELO) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2022: -$468.7K2023: -$3.86M2024: -$5.07M2025: -$3.69M-$3.69M
2022Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$3.69M+27.3%
2024-$5.07M-31.4%
2023-$3.86M-723.6%
2022-$468.7K—